glp 1 agonist eye side effects A potentially blinding condition is a very rare effect of the GLP-1 receptor semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Safety and Tolerability of Glucagon-Like
Description
In humans, unsaturated are more effective than saturated fatty acids [290,291]
MACE: major cardiovascular events
Data on the CV benefits of GLP-1 RAs and their use in clinical practice were summarized
While GLP-1 clearly affects appetite centers in the brain, adding GIP agonism might influence different neural circuits related to food reward, energy expenditure, or metabolic regulation
